C. E. Allen, R. Flores, R. Rauch, R. Dauser, J. C. Murray et al., Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside. Pediatric Blood & Cancer, vol.54, pp.416-423, 2010.

, Diagnostic and Statistical. Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR â ), American Psychiatric Association, 2000.

M. Berres, M. Merad, and C. E. Allen, Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?, British Journal of Haematology, vol.169, pp.3-13, 2015.

J. Donadieu, M. Rolon, C. Thomas, L. Brugieres, D. Plantaz et al.,

S. Cabrol, M. Barthez, K. Hoang-xuan, M. Polak, . French-lch-study et al., Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a populationbased study, The Journal of Pediatrics, vol.144, pp.344-350, 2004.

R. M. Egeler, A. G. Van-halteren, P. C. Hogendoorn, J. D. Laman, and P. J. Leenen, Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage, Immunological Reviews, vol.234, pp.213-232, 2010.

J. Emile, O. Abla, S. Fraitag, A. Horne, J. Haroche et al., Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages, Blood, vol.127, pp.2672-2681, 2016.

N. Grois, D. Prayer, H. Prosch, M. Minkov, U. P?-otschger et al., Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis, Pediatric Blood & Cancer, vol.43, pp.59-65, 2004.

N. Grois, D. Prayer, H. Prosch, H. ;. Lassmann, and . Cns-lch-co-operative-group, Neuropathology of CNS disease in Langerhans cell histiocytosis, Brain: A Journal of Neurology, vol.128, pp.829-838, 2005.

N. Grois, U. P?-otschger, H. Prosch, M. Minkov, M. Arico et al., DALHX-and LCH I and II Study Committee. (2006) Risk factors for diabetes insipidus in langerhans cell histiocytosis, Pediatric Blood & Cancer, vol.46, pp.228-233

N. Grois, B. Fahrner, R. J. Arceci, J. Henter, K. Mcclain et al., Central nervous system disease in Langerhans cell histiocytosis, Histiocyte Society CNS LCH Study Group, vol.156, p.1, 2010.

A. Guyot-goubin, J. Donadieu, M. Barkaoui, S. Bellec, C. Thomas et al., Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, Pediatric Blood & Cancer, vol.51, pp.71-75, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00255977

J. Haroche, F. Cohen-aubart, J. Emile, L. Arnaud, P. Maksud et al., Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation, Blood, vol.121, pp.1495-1500, 2013.

R. Haupt, V. Nanduri, M. G. Calevo, C. Bernstrand, J. L. Braier et al., , 2004.

, Histiocyte Society-Late Effects Study Group, Pediatric Blood & Cancer, vol.42, pp.438-444

R. Haupt, M. Minkov, I. Astigarraga, E. Sch?-afer, V. Nanduri et al., Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years, Pediatric Blood & Cancer, vol.60, pp.175-184, 2013.

S. H-eritier, M. Jehanne, G. Leverger, J. Emile, J. Alvarez et al., Vemurafenib use in an infant for high-risk langerhans cell histiocytosis, JAMA Oncology, vol.1, pp.836-838, 2015.

S. H-eritier, J. Emile, M. Barkaoui, C. Thomas, S. Fraitag et al., BRAF mutation correlates with high-risk langerhans cell histiocytosis and, Journal of Clinical Oncology, vol.34, pp.3023-3030, 2016.

S. H-eritier, Z. Elias-rodzewicz, H. Lapillonne, N. Terrones, S. Garrigou et al., Circulating cell-free BRAF(V600E) as a biomarker in children with Langerhans cell histiocytosis, British Journal of Haematology, vol.178, pp.457-467, 2017.

A. Idbaih, J. Donadieu, M. A. Barthez, F. Geissmann, Y. Bertrand et al., Retinoic acid therapy in 'degenerativelike' neuro-langerhans cell histiocytosis: a prospective pilot study, Pediatric Blood & Cancer, vol.43, pp.55-58, 2004.

S. Imashuku, Y. Shioda, R. Kobayashi, G. Hosoi, H. Fujino et al., Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis, Report from the Japan LCH Study Group. Haematologica, vol.93, pp.615-618, 2008.

S. Imashuku, N. Fujita, Y. Shioda, H. Noma, S. Seto et al., Japan LCH Study Group (JLSG). (2015) Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease, International Journal of Hematology, vol.101, pp.191-197

E. Laurencikas, D. Gavhed, H. St-alemark, I. Van't-hooft, D. Prayer et al., Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population based study. Pediatric Blood & Cancer, vol.56, pp.250-257, 2011.

L. Guennec, L. Decaix, C. Donadieu, J. Santiagoribeiro, M. Martin-duverneuil et al., The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis, Journal of Neurology, vol.261, pp.1537-1543, 2014.

N. Martin-duverneuil, A. Idbaih, K. Hoang-xuan, J. Donadieu, T. Genereau et al., French Langerhans Cell Histiocytosis Study Group. (2006) MRI features of neurodegenerative Langerhans cell histiocytosis. European Radiology, vol.16, pp.2074-2082

E. Mass, C. E. Jacome-galarza, T. Blank, T. Lazarov, B. H. Durham et al., A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease, Nature, vol.549, pp.389-393, 2017.

E. Mittheisz, R. Seidl, D. Prayer, M. Waldenmair, B. Neophytou et al., Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis, Pediatric Blood & Cancer, vol.48, pp.50-56, 2007.

V. R. Nanduri, L. Lillywhite, C. Chapman, L. Parry, J. Pritchard et al., Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study, Journal of Clinical Oncology, vol.21, pp.2961-2967, 2003.

H. Prosch, N. Grois, M. Wnorowski, M. Steiner, and D. Prayer, Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis, American Journal of Neuroradiology, vol.28, pp.1022-1028, 2007.

M. Ribeiro, A. Idbaih, C. Thomas, P. Remy, N. Martin-duverneuil et al., 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease, Journal of Neurology, vol.255, pp.575-580, 2008.

C. Rigaud, M. A. Barkaoui, C. Thomas, Y. Bertrand, A. Lambilliotte et al., Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age, British Journal of Haematology, vol.174, pp.887-898, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01331987

, A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group, Archives of Disease in Childhood, vol.75, pp.17-24, 1996.

D. Wechsler, Wechsler Preschool and Primary Scale of Intelligence -Revised. The Psychological Corporation, 1989.

D. Wechsler, Wechsler Intelligence Scale for Childrenâ-Fourth Edition (WISCâ-IV). Pearson, 2003.

D. Wechsler, Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV), 2008.

M. Wnorowski, H. Prosch, D. Prayer, G. Janssen, H. Gadner et al., Pattern and course of neurodegeneration in Langerhans cell histiocytosis, The Journal of Pediatrics, vol.153, pp.127-132, 2008.